Disc Medicine, Inc.
IRON
$70.03
$1.502.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 76.82M | 65.38M | 54.39M | 45.20M | 37.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 264.75M | 235.17M | 203.60M | 168.76M | 138.20M |
| Operating Income | -264.75M | -235.17M | -203.60M | -168.76M | -138.20M |
| Income Before Tax | -241.31M | -211.82M | -180.66M | -144.93M | -116.02M |
| Income Tax Expenses | 293.00K | 361.00K | 449.00K | 461.00K | 469.00K |
| Earnings from Continuing Operations | -241.60 | -212.18 | -181.11 | -145.39 | -116.49 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -241.60M | -212.18M | -181.11M | -145.39M | -116.49M |
| EBIT | -264.75M | -235.17M | -203.60M | -168.76M | -138.20M |
| EBITDA | -264.40M | -234.89M | -203.40M | -168.64M | -138.05M |
| EPS Basic | -6.61 | -5.98 | -5.35 | -4.47 | -3.92 |
| Normalized Basic EPS | -4.11 | -3.72 | -3.34 | -2.79 | -2.44 |
| EPS Diluted | -6.61 | -5.98 | -5.35 | -4.47 | -3.92 |
| Normalized Diluted EPS | -4.11 | -3.72 | -3.34 | -2.79 | -2.44 |
| Average Basic Shares Outstanding | 146.33M | 141.16M | 133.52M | 128.28M | 118.90M |
| Average Diluted Shares Outstanding | 146.33M | 141.16M | 133.52M | 128.28M | 118.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |